Mr Kenneth Mark Skouby, LCSW | |
515a East Mccarty, Jefferson City, MO 65101 | |
(573) 635-2254 | |
(573) 634-2221 |
Full Name | Mr Kenneth Mark Skouby |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 515a East Mccarty, Jefferson City, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104948769 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | SW002185 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Kenneth Mark Skouby, LCSW 515a East Mccarty Sreet, Jefferson City, MO 65101 Ph: (573) 634-2254 | Mr Kenneth Mark Skouby, LCSW 515a East Mccarty, Jefferson City, MO 65101 Ph: (573) 635-2254 |
News Archive
The Centre for Addiction and Mental Health (CAMH) has signed a licensing agreement with a Massachusetts firm to develop and market an innovative genetic test for a recently identified degenerative muscle disorder. The disorder tends to strike adults in their early 30s.
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that there will be more than 40 presentations at the 10th Biennial ESTRO Conference on Physics and Radiation Technology for Clinical Radiotherapy that explore use of the TomoTherapy® treatment system. The TomoTherapy system - a versatile, CT scanner-based device that integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting - is helping cancer centers advance patient care around the world.
Aptiv Solutions and Cancer Genetics, Inc. (CGI) have formed a strategic partnership focused on delivering comprehensive solutions to biopharmaceutical and medical device firms conducting clinical trials for oncology therapeutics.
neuMirRx Corp today welcomed the issuance of U.S. patent 7,345,093, entitled "Methods for Enhancing Solubility of Compounds" which covers novel formulation methods to enhance the solubility of hydrophobic compounds.
In addition to providing a simple and much less expensive means of making artemisinin, the most powerful anti-malaria drug in use today, synthetic biology can also help to extend the effectiveness of this drug.
› Verified 4 days ago
Eric Thomas Lybeck-brown, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 211 Oscar Dr, Suite A, Jefferson City, MO 65101 Phone: 573-635-8299 Fax: 573-635-4629 | |
Ms. Jennie M Harvat, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 227 Metro Dr, Jefferson City, MO 65109 Phone: 888-403-1071 | |
Eileen Long, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1001 Southwest Blvd, Ste. F, Jefferson City, MO 65109 Phone: 573-424-1108 | |
Prof. Deborah Word, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 909 Missouri Blvd, Suite F, Jefferson City, MO 65109 Phone: 573-584-0158 Fax: 573-584-0159 | |
John Starke, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 227 Metro Dr, Jefferson City, MO 65109 Phone: 844-853-8937 | |
Alvin Bexten, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3016 Dupont Cir, Jefferson City, MO 65109 Phone: 888-403-1071 |